SCHEMBL9517291

SCHEMBL9517291

CCCCNC(=O)c1ccc(S(=O)(=O)NC(=O)c2ccc(COCc3ccccc3)nc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 6/20 0.47
MCL1 Q07820 6/20 0.47
P4HTM Q9NXG6 3/20 0.46
MEN1 O00255 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
KMT2A Q03164 1/20 0.44
ALDH1A1 P00352 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
CA2 P00918 1/20 0.42
OPRK1 P41145 1/20 0.42
NAAA Q02083 1/20 0.41
HDAC3 O15379 2/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9516970 0.94 BCL2L1 (0.48) BCL2L1MCL1P4HTMMEN1NPC1
SCHEMBL9516250 0.89 CA2 (0.46) P4HTMNPC1RAB9AKMT2AALDH1A1
SCHEMBL9518145 0.86 P4HTM (0.61) BCL2L1MCL1P4HTM
SCHEMBL9515759 0.84 P4HTM (0.58) BCL2L1MCL1P4HTMNPC1RAB9A
SCHEMBL9517158 0.83 NPC1 (0.46) BCL2L1MCL1P4HTMNPC1RAB9A
SCHEMBL9517102 0.83 NPC1 (0.49) BCL2L1MCL1P4HTMMEN1NPC1
SCHEMBL9515740 0.82 RAB9A (0.48) BCL2L1MCL1P4HTMMEN1NPC1
SCHEMBL9517095 0.82 RAB9A (0.48) BCL2L1MCL1P4HTMMEN1NPC1
SCHEMBL9515765 0.82 HSP90AA1 (0.46) BCL2L1MCL1P4HTMNPC1RAB9A
SCHEMBL8870207 0.81 CA2 (0.48) BCL2L1MCL1P4HTMMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed